ProShare Advisors’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
Sell
-29,142
Closed -$237K 2591
2013
Q2
$237K Buy
+29,142
New +$215K ﹤0.01% 1903

Other funds holding TSRX

ProShare Advisors's TSRX Position: Q3 2013 in Review

ProShare Advisors sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 29,142 shares — an estimated $237K sold.

ProShare Advisors first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $237K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

  • ProShare Advisors reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • ProShare Advisors sold 29,142 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $237K.
  • ProShare Advisors first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • ProShare Advisors's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $237K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on ProShare Advisors's 13F filing for Q3 2013, filed 7 Nov 2013.